| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |